Both in Pharmaceuticals
Assembly Biosciences vs Lyell Immunopharma
Over the past year ASMB returned −36.8% and LYEL returned −3.3%; their daily moves had a correlation of 0.36.
ASMB −36.8% LYEL −3.3%Growth of $1, one year, split-adjusted
| Metric | ASMB | LYEL |
|---|---|---|
| Price | $19.87 | $15.43 |
| Market cap | $404.6M | $378.1M |
| Today | −0.25% | +43.27% |
| 1 month | −10.4% | +79.2% |
| 6 months | −36.6% | −26.0% |
| Year to date | −41.6% | −49.9% |
| 1 year | −36.3% | −6.8% |
| Revenue growth (YoY) | +38.9% | −50.0% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −28.8% | −1118875.0% |
| P/E (TTM) | — | — |
| Price / sales | 5.4× | 14,004.2× |
| Net cash | $320.4M | $204.1M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 101.1% |
| Short % of float | 28.0% | 15.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).